HEMATOLOGICAL MALIGNANCY

Clinical trials for HEMATOLOGICAL MALIGNANCY explained in plain language.

Never miss a new study

Get alerted when new HEMATOLOGICAL MALIGNANCY trials appear

Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2 Terminated 1

New hope for tough blood cancers: experimental drug SG301 enters human testing

Disease control Ongoing

This early-stage trial tests a new drug called SG301 in 61 people with blood cancers like multiple myeloma that have returned or stopped responding to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it helps fight the cancer. Par…

Matched conditions: HEMATOLOGICAL MALIGNANCY

Phase: PHASE1 • Sponsor: Hangzhou Sumgen Biotech Co., Ltd. • Aim: Disease control

Last updated Jun 05, 2026 12:09 UTC

HEMATOLOGICAL MALIGNANCY

Get alerted when new HEMATOLOGICAL MALIGNANCY trials appear

New hope for tough blood cancers: experimental drug SG301 enters human testing